AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture.
The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support.
It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization.
The company serves biotechnology and biopharmaceutical industries.
The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018.
Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Country | United States |
IPO Date | Apr 4, 1994 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 371 |
CEO | Nicholas Stewart Green B.Sc., MBA |
Contact Details
Address: 2642 Michelle Drive Tustin, California United States | |
Website | https://www.avidbio.com |
Stock Details
Ticker Symbol | CDMO |
Exchange | NASDAQ |
Fiscal Year | May - April |
Reporting Currency | USD |
CIK Code | 0000704562 |
CUSIP Number | 05368M106 |
ISIN Number | US05368M1062 |
Employer ID | 95-3698422 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Nicholas Stewart Green B.Sc., MBA | President, Chief Executive Officer & Director |
Daniel R. Hart | Chief Financial Officer |
Mark R. Ziebell J.D. | Vice President, General Counsel & Corporate Secretary |
Matthew R. Kwietniak | Chief Commercial Officer |
Richard A. Richieri | Chief Operations Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Jan 13, 2025 | 4 | Filing |
Jan 08, 2025 | DEFA14A | Filing |
Jan 08, 2025 | DEFA14A | Filing |
Jan 02, 2025 | 4 | Filing |
Jan 02, 2025 | 4 | Filing |
Jan 02, 2025 | 4 | Filing |
Dec 30, 2024 | DEFA14A | Filing |
Dec 27, 2024 | 4 | Filing |
Dec 27, 2024 | 4 | Filing |